Insider Selling: MedEquities Realty Trust Inc (MRT) Director Sells 28,027 Shares of Stock

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 28,027 shares of the business’s stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $7.52, for a total value of $210,763.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Wednesday, November 14th, Bluemountain Capital Managemen sold 57,234 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $7.81, for a total value of $446,997.54.
  • On Monday, November 12th, Bluemountain Capital Managemen sold 37,530 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.74, for a total value of $328,012.20.
  • On Thursday, November 8th, Bluemountain Capital Managemen sold 35,783 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.60, for a total value of $307,733.80.
  • On Tuesday, November 6th, Bluemountain Capital Managemen sold 25,765 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.58, for a total value of $221,063.70.
  • On Friday, November 2nd, Bluemountain Capital Managemen sold 25,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.39, for a total value of $209,750.00.
  • On Wednesday, October 31st, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.45, for a total value of $84,500.00.
  • On Monday, October 29th, Bluemountain Capital Managemen sold 11,695 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.39, for a total value of $98,121.05.
  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $8.45, for a total value of $215,863.70.
  • On Monday, October 22nd, Bluemountain Capital Managemen sold 5,463 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.65, for a total value of $47,254.95.
  • On Friday, October 19th, Bluemountain Capital Managemen sold 5,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.54, for a total value of $42,700.00.

Shares of MRT stock opened at $7.42 on Tuesday. MedEquities Realty Trust Inc has a 12-month low of $7.32 and a 12-month high of $12.00. The stock has a market capitalization of $239.29 million, a PE ratio of 6.65 and a beta of 0.65.

MedEquities Realty Trust (NYSE:MRT) last issued its earnings results on Monday, November 12th. The financial services provider reported ($0.07) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.18 by ($0.25). MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. The firm had revenue of $9.68 million during the quarter, compared to the consensus estimate of $17.72 million. On average, research analysts anticipate that MedEquities Realty Trust Inc will post 1.08 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently modified their holdings of the business. Los Angeles Capital Management & Equity Research Inc. bought a new stake in MedEquities Realty Trust during the second quarter worth approximately $131,000. People s United Financial Inc. bought a new stake in MedEquities Realty Trust during the second quarter worth approximately $158,000. Bank of Montreal Can bought a new stake in MedEquities Realty Trust during the second quarter worth approximately $160,000. California Public Employees Retirement System bought a new stake in MedEquities Realty Trust during the second quarter worth approximately $171,000. Finally, Raymond James Trust N.A. bought a new stake in MedEquities Realty Trust during the third quarter worth approximately $161,000. 90.81% of the stock is currently owned by institutional investors.

MRT has been the topic of several research reports. Zacks Investment Research cut MedEquities Realty Trust from a “buy” rating to a “hold” rating in a report on Saturday, August 11th. JMP Securities set a $12.00 target price on MedEquities Realty Trust and gave the stock a “buy” rating in a report on Tuesday, October 23rd. Citigroup cut MedEquities Realty Trust from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $10.00 to $9.00 in a report on Friday, September 14th. ValuEngine cut MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 8th. Finally, KeyCorp cut MedEquities Realty Trust from an “overweight” rating to a “hold” rating and set a $12.00 target price on the stock. in a report on Wednesday, August 8th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $11.13.

WARNING: “Insider Selling: MedEquities Realty Trust Inc (MRT) Director Sells 28,027 Shares of Stock” was published by WKRB News and is the sole property of of WKRB News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.wkrb13.com/2018/11/20/insider-selling-medequities-realty-trust-inc-mrt-director-sells-28027-shares-of-stock.html.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Recommended Story: What is a bull market?

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply